tradingkey.logo

tradingkey.logo
怜玢


Check Cap Ltd

CHEK
りォッチリストに远加
1.610USD
0.0000.00%
終倀 05/15, 16:00ET15分遅れの株䟡
12.43M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Check Cap Ltd 䌁業名

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

Check Cap Ltdの䌁業情報


䌁業コヌドCHEK
䌚瀟名Check Cap Ltd
䞊堎日Feb 19, 2015
最高経営責任者「CEO」Ovadia (Alex)
埓業員数- -
蚌刞皮類Ordinary Share
決算期末Feb 19
本瀟所圚地29 Abba Hushi Ave.
郜垂
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Israel
郵䟿番号3009000
電話番号97248303401
りェブサむトhttps://check-cap.com/
䌁業コヌドCHEK
䞊堎日Feb 19, 2015
最高経営責任者「CEO」Ovadia (Alex)

Check Cap Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Mr. Yuval Yanai
Mr. Yuval Yanai
Independent Director
Independent Director
--
--
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
--
--
Dr. Mary Jo Gorman, M.D.
Dr. Mary Jo Gorman, M.D.
Independent Director
Independent Director
--
--
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
--
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
--
--
Mr. Joshua (Shuki) Belkar
Mr. Joshua (Shuki) Belkar
Vice President - Operations
Vice President - Operations
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Mr. Yuval Yanai
Mr. Yuval Yanai
Independent Director
Independent Director
--
--
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
--
--
Dr. Mary Jo Gorman, M.D.
Dr. Mary Jo Gorman, M.D.
Independent Director
Independent Director
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sat, Feb 7
曎新時刻: Sat, Feb 7
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
EquityLine Alternate Assets GP Inc
10.86%
Ramanathan (Vijay)
5.13%
Symetryx Corp
4.82%
UBS Switzerland AG
0.25%
UBS Financial Services, Inc.
0.07%
他の
78.86%
株䞻統蚈
株䞻統蚈
比率
EquityLine Alternate Assets GP Inc
10.86%
Ramanathan (Vijay)
5.13%
Symetryx Corp
4.82%
UBS Switzerland AG
0.25%
UBS Financial Services, Inc.
0.07%
他の
78.86%
皮類
株䞻統蚈
比率
Corporation
15.69%
Individual Investor
5.13%
Bank and Trust
0.30%
Research Firm
0.22%
Investment Advisor
0.08%
Investment Advisor/Hedge Fund
0.08%
他の
78.50%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
30
47.75K
0.68%
-132.99K
2025Q4
31
46.22K
2.97%
--
2025Q3
31
46.22K
2.97%
-83.61K
2025Q2
30
129.91K
3.13%
+25.59K
2025Q1
31
104.32K
4.46%
-156.41K
2024Q4
32
147.67K
2.55%
+134.65K
2024Q3
33
13.02K
3.40%
+4.10K
2024Q2
36
9.37K
3.50%
-1.09K
2024Q1
41
13.66K
3.76%
-206.06K
2023Q4
43
68.48K
6.43%
+25.25K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
EquityLine Alternate Assets GP Inc
762.72K
10.46%
--
--
Dec 31, 2024
Ramanathan (Vijay)
360.00K
4.94%
--
--
Dec 31, 2024
Symetryx Corp
338.63K
4.65%
--
--
Dec 31, 2024
UBS Switzerland AG
637.00
0.01%
+433.00
+212.25%
Dec 31, 2025
UBS Financial Services, Inc.
7.35K
0.1%
+6.88K
+1444.75%
Dec 31, 2025
BNP Paribas Securities Corp. North America
12.44K
0.17%
-9.20K
-42.52%
Dec 31, 2025
National Bank of Canada
3.27K
0.04%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
2.93K
0.04%
--
--
Jan 31, 2026
Dimensional Fund Advisors, L.P.
8.96K
0.12%
--
--
Dec 31, 2025
J.P. Morgan Securities LLC
1.50K
0.02%
--
--
Dec 31, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
日付
配圓萜ち日
皮類
比率
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
KeyAI
î™